EarlyCDT-Lung requires a very small sample of blood that is analyzed in our CLIA laboratory in Kansas

EarlyCDT-Lung requires a physician order

Physicians in the US whose healthcare organisation uses ARUP, MACL or PAML as a send out reference laboratory can order EarlyCDT-Lung and get the results through their EMR. Please call 1-888-583-9030 or email clientservices@oncimmune.com for any assistance

Alternatively, order our sample collection kit – it includes everything physicians need to get the test directly from Oncimmune

With our collection kit, patients can provide their own blood sample for the test using our simple finger stick kit, or blood can be drawn by a phlebotomist or physician in the normal way

The collection kit includes everything for either method of blood draw, so the physician can decide this with each patient

Our collection kit also includes

  • the Test Requisition Form to order the test which requires a physician’s signature
  • A patient brochure
  • Instructions for taking the sample by finger stick or regular phlebotomy draw
  • Prepaid FEDEX envelope to send sample
  • Samples are shipped overnight inside the US at ambient temperature
  • Outside the USA, samples must be shipped through our distributors

To set up a sample collection processing agreement for blood draws in the US, call 1-888-583-9030 or email clientservices@oncimmune.com


Electronic versions of the materials you are seeking to access are being made available on this website by Oncimmune Holdings plc (the “Company”).

These materials are not directed to nor are they intended for access by persons located or resident in the United States, Australia, Canada, South Africa, Japan or any other jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.

None of the securities of Company discussed or referred to in the materials you are seeking to access have been registered under the US Securities Act or 1933, as amended (the “Securities Act”) and may not be offered, sold, pledged or otherwise transferred except (1) in an offshore transaction meeting the requirements of Rule 903 or Rule 904 of Regulation S under the Securities Act, (2) pursuant to an effective registration statement under the Securities Act, or (3) pursuant to an available exemption from the registration requirements of the Securities Act, in each case in accordance with all applicable securities laws.

By clicking the “SUBMIT” button below you confirm that you (1) have read and understood the information set out above, (2) agree to be bound by its terms, (3) are not located in the United States and do not have a registered address in, and are not resident or located in, Australia, Canada, South Africa or Japan and (4) are permitted under applicable law and regulation to proceed to the following parts of this website.

Please click on the button below to confirm that you have read, understood and agree with the disclaimer above.

Yes, I accept No, I don't accept